Reports from cancer studies demonstrated that NDRG2 inhibits c-Myc expression by suppressing the expression of β-catenin[101] and reduces c-Jun phosphorylation and cyclin D1 expression resulting in suppression of cell proliferation in human colon carcinoma cells[102]. Here, MYC is linked to colon carcinoma.